Literature DB >> 27018165

Neurobiology of Kratom and its main alkaloid mitragynine.

Farah W Suhaimi1, Nurul H M Yusoff1, Rahimah Hassan1, Sharif M Mansor1, Visweswaran Navaratnam1, Christian P Müller2, Zurina Hassan3.   

Abstract

Kratom or its main alkaloid, mitragynine is derived from the plant Mitragyna speciosa Korth which is indigenous to Southeast Asian countries. This substance has become widely available in other countries like Europe and United States due to its opium- and coca-like effects. In this article, we have reviewed available reports on mitragynine and other M. speciosa extracts. M. speciosa has been proven to have a rewarding effect and is effective in alleviating the morphine and ethanol withdrawal effects. However, studies in human revealed that prolonged consumption of this plant led to dependence and tolerance while cessation caused a series of aversive withdrawal symptoms. Findings also showed that M. speciosa extracts possess antinociceptive, anti-inflammatory, anti-depressant, and muscle relaxant properties. Available evidence further supports the adverse effects of M. speciosa preparations, mitragynine on cognition. Pharmacological activities are mainly mediated via opioid receptors as well as neuronal Ca2+ channels, expression of cAMP and CREB protein and via descending monoaminergic system. Physicochemical properties of mitragynine have been documented which may further explain the variation in pharmacological responses. In summary, current researchs on its main indole alkaloid, mitragynine suggest both therapeutic and addictive potential but further research on its molecular effects is needed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27018165     DOI: 10.1016/j.brainresbull.2016.03.015

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  15 in total

1.  The Right to Use Kratom from the Psychiatric and Islamic Perspectives.

Authors:  Mohammad Farris Iman Leong Bin Abdullah; Mohd Afifuddin Mohamad; Noor Naemah Abdul Rahman
Journal:  J Relig Health       Date:  2021-04

2.  The respiratory depressant effects of mitragynine are limited by its conversion to 7-OH mitragynine.

Authors:  Rob Hill; Andrew C Kruegel; Jonathan A Javitch; J Robert Lane; Meritxell Canals
Journal:  Br J Pharmacol       Date:  2022-03-30       Impact factor: 9.473

3.  Kratom Use Among U.S. Adolescents: Analyses of the 2019 National Survey on Drug Use and Health.

Authors:  Vinita Sharma; Linda B Cottler; Cristina B Bares; Catalina Lopez-Quintero
Journal:  J Adolesc Health       Date:  2021-11-23       Impact factor: 7.830

4.  Posterior reversible leukoencephalopathy syndrome after kratom ingestion.

Authors:  Austin Castillo; J Drew Payne; Kenneth Nugent
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

5.  In silico and in vitro anti-AChE activity investigations of constituents from Mytragyna speciosa for Alzheimer's disease treatment.

Authors:  Wansiri Innok; Asadhawut Hiranrat; Netnapa Chana; Thanyada Rungrotmongkol; Panita Kongsune
Journal:  J Comput Aided Mol Des       Date:  2021-01-13       Impact factor: 3.686

6.  The ethnobotany of psychoactive plant use: a phylogenetic perspective.

Authors:  Nashmiah Aid Alrashedy; Jeanmaire Molina
Journal:  PeerJ       Date:  2016-10-05       Impact factor: 2.984

Review 7.  Herbal Highs: Review on Psychoactive Effects and Neuropharmacology.

Authors:  Silvia Graziano; Laura Orsolini; Maria Concetta Rotolo; Roberta Tittarelli; Fabrizio Schifano; Simona Pichini
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 8.  Biochemical Benefits, Diagnosis, and Clinical Risks Evaluation of Kratom.

Authors:  Dimy Fluyau; Neelambika Revadigar
Journal:  Front Psychiatry       Date:  2017-04-24       Impact factor: 4.157

Review 9.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157

Review 10.  A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans.

Authors:  Elisabeth Prevete; Kim Paula Colette Kuypers; Eef Lien Theunissen; Ornella Corazza; Giuseppe Bersani; Johannes Gerardus Ramaekers
Journal:  Hum Psychopharmacol       Date:  2021-07-26       Impact factor: 2.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.